Ondansetron

Type: Product
Name: Ondansetron
First reported 13 hours ago - Updated 5 hours ago - 1 reports

Galena Gives Sales Team Another Useless Product to Promote

By: | 07/22/14 - 09:41 AM EDTGalena BioPharma ( GALE ) CEO Mark Ahn continues to shell out big money for obsolete, rarely prescribed drug products.Tuesday, Galena entered into a license agreement with MonoSol Rx for Zuplenz, an oral dissolvable film ... [Published TheStreet.com - 13 hours ago]
Entities: Ondansetron, Drugs, Sales
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Galena licenses powerful anti-nausea drug in U.S.

Cancer patients in the United States soon will have better relief from nausea caused by chemotherapy and radiation therapy, thanks to a Portland-based biopharmaceutical company.Portland-based Galena Biopharma Inc. announced today that it has licensed ... [Published Business First of Buffalo - 6 hours ago]
First reported 16 hours ago - Updated 9 hours ago - 4 reports

Galena Licenses U.S. Rights to Zuplenz Oral Film for $5M+

Galena Biopharma will license U.S. rights to the oral soluble film (OSF) formulation of Zuplenz® (ondansetron) for nausea and vomiting in cancer patients from its co-developer and manufacturer MonoSol Rx for more than $5 million, the companies said t ... [Published Genetic Engineering News - 12 hours ago]
First reported Jul 20 2014 - Updated Jul 20 2014 - 1 reports

Newman's Notes: Inside the Ondansetron Black Box (CME/CE)

(MedPage Today) -- Emergency physician David H. Newman, MD, dissects the ondansetron black box warning. ... [Published MedPageToday.com - medical news plus CME for ph ... - Jul 20 2014]
Entities: Ondansetron, emergency
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

"Non-Mucoadhesive Film Dosage Forms" in Patent Application Approval Process

By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Leichs, Christian (Burscheid, DE); Breitenbach, Armin (Leverkusen, DE); Lehrke, Ingo (Koln, DE); Galfetti, Paolo (IT, IT), filed on October 11, 2013, was made available ... [Published Pharmacy Choice - Jul 18 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

ONDANSETRON Tablet, Orally Disintegrating [Cardinal Health]

First reported Jul 04 2014 - Updated Jul 04 2014 - 1 reports

Aprepitant Prevents CINV in Young Cancer Patients Also

Aprepitant ( Emend , Merck & Co.), which is already approved for use in adults for the prevention of chemotherapy-induced nausea and vomiting (CINV), has now been shown to also be effective in children and adolescents (ranging from 6 months to 17 yea ... [Published American Journal of Public Health - Jul 04 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

Emend Eases Children’s Chemotherapy-Induced Nausea and Vomiting, Study Shows

Merck plans FDA submission in second half of 2014The addition of Emend (aprepitant, Merck) to a standard treatment regimen significantly reduced chemotherapy-induced nausea and vomiting (CINV) in pediatric cancer patients in a large phase III trial.The ... [Published P&T Community - Jun 30 2014]
First reported Jun 30 2014 - Updated Jun 30 2014 - 1 reports

When side effects can be used to help patients

While over-medication is harmful, the adverse effects of drugs can be turned to therapeutic advantage The suspicion that over-medication with preventive drugs may shorten, rather than prolong, life was strikingly confirmed in a recent study of nearly ... [Published Telegraph - Jun 30 2014]
First reported Jun 29 2014 - Updated Jun 29 2014 - 1 reports

Aprepitant Yields Significant Benefits for the Prevention of CINV in Children

Peter J. Sciavolino, PhDIn the first large pediatric study of adding the NK-1 receptor antagonist aprepitant to standard prophylaxis for chemotherapy-induced nausea and vomiting (CINV), researchers have found aprepitant to be significantly more effective ... [Published OncLive - Jun 29 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Morning sickness drug linked to birth defects: Report

Photo: iStockphotoYesterday, the  Toronto Star  reported that an unapproved anti-nausea drug used for morning sickness is linked to birth defects. The drug—ondansetron—is being prescribed by doctors for Hyperemesis gravidarum (the kind of extreme morning ... [Published Today's Parent - Jun 26 2014]
First reported Jun 25 2014 - Updated Jun 26 2014 - 1 reports

Birth defects blamed on unapproved morning sickness treatment

Canadian women with severe morning sickness are being prescribed a powerful anti-nausea drug suspected of causing deformities in some babies, a Toronto Star investigation has found.The drug, ondansetron, is approved by Health Canada to treat nausea and ... [Published Toronto Star Online - Jun 25 2014]

Quotes

Added Keith J Kendall, MonoSol Rx’ co-president and COO: "Through this partnership, we hope to empower supportive care providers with a more comfortable, easier-to-use formulation of ondansetron that addresses a significant unmet medical need, particularly among cancer patients."
...working with MonoSol Rx to offer Zuplenz to patients in need," said Mark J Ahn, Ph D , President and Chief Executive Officer of Galena Biopharma. "MonoSol Rx's oral film delivery technology represents a substantive advancement in terms of ease of use and compliance for supportive care patients, where difficulty swallowing can be a major issue. Providing patients with an alternative solution for nausea and vomiting has long been a concept that oncologists and the general surgeon and oncology nurse communities have sought, and that we are eager to deploy."
...acceleration and leverage to our commercial product portfolio," said Mark J Ahn , Ph D , President and Chief Executive Officer of Galena Biopharma.  "Our commercial franchise was established last year with the acquisition of Abstral® for the treatment of breakthrough cancer pain. Adding Zuplenz to our commercial portfolio enhances our offering of supportive care products that are simple to take and provide reliable dosing to improve the quality of life for patients suffering from cancer or recovering from surgery and the associated side-effects."

More Content

All (66) | News (33) | Reports (0) | Blogs (28) | Audio/Video (0) | Fact Sheets (1) | Press Releases (4)
sort by: Date | Relevance
Galena licenses powerful anti-nausea drug in U.S. [Published Business First of Buffalo - 6 hours ago]
MonoSol Rx signs licensing agreement with Galen... [Published Individual.com - 9 hours ago]
Galena Licenses U.S. Rights to Zuplenz Oral Fil... [Published Genetic Engineering News - 12 hours ago]
Galena Gives Sales Team Another Useless Product... [Published TheStreet.com - 13 hours ago]
Galena secures U.S. rights to serotonin blocker [Published Seeking Alpha - 15 hours ago]
MonoSol Rx Enters Into Exclusive Licensing Agre... [Published BusinessWeek - 16 hours ago]
Galena Biopharma Enters Into Definitive Agreeme... [Published GlobeNewswire: Advertising News - 16 hours ago]
Galena Biopharma : Enters Into Definitive Agree... [Published 4 Traders - 16 hours ago]
Newman's Notes: Inside the Ondansetron Black Bo... [Published MedPageToday.com - medical news plus CME for ph ... - Jul 20 2014]
"Non-Mucoadhesive Film Dosage Forms" in Patent ... [Published Pharmacy Choice - Jul 18 2014]
RedHill Biopharma to Host Second Quarter 2014 F... [Published Benzinga.com - Jul 16 2014]
RedHill Biopharma (PINK:REDIF) Acquires Phase I... [Published Live Trading News - Jul 14 2014]
ONDANSETRON Tablet, Film Coated [Bryant Ranch P... [Published DailyMed Drug Label Updates for the last seven ... - Jul 11 2014]
ONDANSETRON Tablet, Film Coated [Bryant Ranch P... [Published DailyMed Drug Label Updates for the last seven ... - Jul 11 2014]
ONDANSETRON Tablet, Orally Disintegrating [Card... [Published DailyMed Drug Label Updates for the last seven ... - Jul 10 2014]
The problem with off-label drugs [Published Toronto Star Online - Jul 05 2014]
Aprepitant Prevents CINV in Young Cancer Patien... [Published American Journal of Public Health - Jul 04 2014]
RedHill Acquires Mesupron from Wilex [Published Yahoo! Finance - Jul 03 2014]
Gastroparesis [Published Today's Dietitian - Jul 03 2014]
Emend Eases Children’s Chemotherapy-Induced Nau... [Published P&T Community - Jun 30 2014]
RedHill Biopharma Acquires Phase II Oncology Dr... [Published GlobeNewswire - Jun 30 2014]
When side effects can be used to help patients [Published Telegraph - Jun 30 2014]
Aprepitant Yields Significant Benefits for the ... [Published OncLive - Jun 29 2014]
Morning sickness drug linked to birth defects: ... [Published Today's Parent - Jun 26 2014]
RedHill Biopharma Announces Positive Preliminar... [Published Market Pulse Navigator - Jun 26 2014]
Dangers of off-label drug use kept secret [Published Toronto Star Online - Jun 26 2014]
Birth defects blamed on unapproved morning sick... [Published Toronto Star Online - Jun 25 2014]
Tender for the delivery of cytostatics, adjuvan... [Published Pharmacy Choice - Jun 20 2014]
Drug Combating Severe Nausea in Pregnancy Begin... [Published HealthNewsDigest.com - Jun 18 2014]
Forum Post: RE: Any advice on dosetaxel please [Published Macmillan Cancer Support - Jun 14 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Newman's Notes: Inside the Ondansetron Black Bo... [Published MedPageToday.com - medical news plus CME for ph ... - Jul 20 2014]
(MedPage Today) -- Emergency physician David H. Newman, MD, dissects the ondansetron black box warning. ...
ONDANSETRON Tablet, Film Coated [Bryant Ranch P... [Published DailyMed Drug Label Updates for the last seven ... - Jul 11 2014]
Updated Date: Jul 11, 2014 EST ...
ONDANSETRON Tablet, Film Coated [Bryant Ranch P... [Published DailyMed Drug Label Updates for the last seven ... - Jul 11 2014]
Updated Date: Jul 11, 2014 EST ...
ONDANSETRON Tablet, Orally Disintegrating [Card... [Published DailyMed Drug Label Updates for the last seven ... - Jul 10 2014]
Updated Date: Jul 10, 2014 EST ...
ONDANSETRON Tablet, Film Coated [Proficient Rx LP] [Published DailyMed Drug Label Updates for the last seven ... - Jun 04 2014]
Updated Date: Jun 4, 2014 EST ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
Galena Biopharma Enters Into Definitive Agreeme... [Published GlobeNewswire: Advertising News - 16 hours ago]
RedHill Biopharma Reports Successful RHB-102 Bi... [Published GlobeNewswire: Advertising News - Apr 30 2014]
RedHill Biopharma Announces Positive European S... [Published GlobeNewswire: Advertising News - Apr 07 2014]
RedHill Biopharma Provides Update on RHB-102 De... [Published GlobeNewswire: Acquisitions News - Mar 07 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.